Fig. 2: Genetic deletion of Cyp11a1 in immune cells alters TNBC tumour dynamics and the immune landscape of the TME.
From: Perturbing local steroidogenesis to improve breast cancer immunity

A Schematic illustration depicting the experimental strategy. B Subcutaneous E0771.LMB tumour growth curve of control versus Cyp11a1cKO mice; each data point represents average tumour size (N = 12; Two-way ANOVA for growth curves). C Representative photograph of E0771.LMB tumour in control and Cyp11a1cKO mice. D Bar chart showing the scaled concentrations of steroid hormones detected in the tumours from control and Cyp11a1cKO mice via LC-MS (N = 6 for control and N = 9 for Cyp11a1cKO). E t-SNE plots of CD45+ immune cells from control (N = 3) and Cyp11a1cKO (N = 3) mice. Different colours on the left highlight distinct immune cell subsets, while the right contrasts cell origins from control versus Cyp11a1cKO mice. F Marker gene expression across immune cell clusters of panel (E). G Relative percentages of immune cell populations between Vav1Cre control and Cyp11a1cKO mice (N = 3). H Differential M1 macrophage scores in macrophages extracted from Vav1Cre control versus Cyp11a1cKO mice. Each dot represents a single cell. The box plot shows the median as the center, the 25th and 75th percentiles as the box boundaries, whiskers extending to the most extreme values within 1.5×IQR from the quartiles, and outliers plotted separately. I Dot plot presentation of M1 versus M2 gene expression in macrophages sourced from both Vav1Cre control and Cyp11a1cKO mice. J–L Flow cytometry profiles emphasising Mertk (J), iNos (K) and Arg1 (L) expression in CD11b+ cells from Vav1Cre and Cyp11a1cKO mice (left). The adjoining chart (right) showcases the percentage expression for each group. N = 4 (J), N = 3 (K), N = 5 (L). All experiments are representative of two or three independent repeats except (D–G). All error bars except H: Mean ± SEM; p values were calculated using unpaired two-tailed t-test unless stated. Source data for B, D, J & K are provided as a Source Data file. Figure 2A was partly generated using Servier Medical Art, licensed under a CC BY 4.0 license.